Details for: AUBAGIO
Company: SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02416328 | AUBAGIO | TERIFLUNOMIDE | 14 MG | TABLET | ORAL |
Summary Reports
Summary Basis of Decision
Summary Safety Review - AUBAGIO (teriflunomide) - Assessing the potential risk of inflammation of the colon (colitis)
Summary Safety Review - Aubagio (teriflunomide) - Assessing the potential risk of sudden kidney injury or kidney stones
Summary Safety Review - AUBAGIO (teriflunomide) - Assessing the potential risk of inflammation of the colon (colitis)
Summary Safety Review - Aubagio (teriflunomide) - Assessing the potential risk of sudden kidney injury or kidney stones
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.